RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment

Published:2018-06-27 Issue:5 Volume:9 Page:326-337
ISSN:1868-8497
Container-title:Hormones and Cancer
language:en
Short-container-title:HORM CANC

Author:

Hellweg Raffaele,Mooneyham Ashley,Chang Zenas,Shetty Mihir,Emmings Edith,Iizuka Yoshie,Clark Christopher,Starr Timothy,Abrahante Juan H.,Schütz Florian,Konecny Gottfried,Argenta Peter,Bazzaro Martina

Funder

Department of Defense Ovarian Cancer Research Program

Cancer Biology Training Grant NIH T32

Minnesota Ovarian Cancer Alliance

Randy Shaver Community Funds

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Endocrine and Autonomic Systems,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/article/10.1007/s12672-018-0337-6/fulltext.html

Reference60 articles.

1. DeSantis CE et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin 66(4):290–308

2. Lheureux S, Wilson M, Mackay HJ (2014) Recent and current Phase II clinical trials in endometrial cancer: review of the state of art. Expert Opin Investig Drugs 23(6):773–792

3. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289

4. Burstein HJ, Krilov L, Aragon-Ching JB, Baxter NN, Chiorean EG, Chow WA, de Groot JF, Devine SM, DuBois SG, el-Deiry WS, Epstein AS, Heymach J, Jones JA, Mayer DK, Miksad RA, Pennell NA, Sabel MS, Schilsky RL, Schuchter LM, Tung N, Winkfield KM, Wirth LJ, Dizon DS (2017) Clinical cancer advances 2017: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 35(12):1341–1367

5. Kumar S, Sharghi-Namini S, Rao N, Ge R (2012) ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity. Am J Pathol 181(3):1056–1068

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling;International Journal of Molecular Sciences;2023-12-13

2. Metal Complexes in Cancer Treatment: Journey So Far;Chemistry & Biodiversity;2023-03-13

3. Identification of drug-resistant cancer cells in flow cytometry combining 3D holographic tomography with machine learning;Sensors and Actuators B: Chemical;2023-01

4. Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth;Cancers;2022-11-02

5. Oxidation and reduction of actin: Origin, impact in vitro and functional consequences in vivo;European Journal of Cell Biology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3